Xeris Biopharma Holdings Inc
XERS
Market Cap$444.02M
Close$
$2.89
3% downside
Current Fair Value
3% downsideOvervalued by 3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $444.02 Million |
|---|---|
| Enterprise Value | $656.22 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.45 |
| Beta | 1.31 |
| Outstanding Shares | 148,345,549 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.42 |
|---|---|
| PEG | 30.45 |
| Price to Sales | 2.98 |
| Price to Book Ratio | -2.98 |
| Enterprise Value to Revenue | 3.62 |
| Enterprise Value to EBIT | -16.45 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -13.99 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick